Skip to main content

Table 3 Association between GLR and the risk of recurrence of HCC with staging I–II

From: Non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging I–II: a retrospective cohort study

Exposure

Non-adjusted

Adjust I

Adjust II

GLR

1.003 (1.002, 1.004) < 0.00001

1.003 (1.002, 1.004) < 0.00001

1.002 (1.001, 1.004) 0.00884

GLR tertiles

 Low

1.0

1.0

1.0

 Middle

1.899 (1.308, 2.758) 0.00075

1.827 (1.254, 2.660) 0.00168

1.748 (1.170, 2.612) 0.00644

 High

2.375 (1.646, 3.426) < 0.00001

2.263 (1.565, 3.273) 0.00001

2.078 (1.339, 3.227) 0.00112

P for trend

 < 0.00001

0.00001

0.00127

  1. Data presented were HRs and 95% CIs. Non-adjusted model adjusted for: None; Adjust I model adjusted for: age; sex; Adjust II model adjusted for: age; sex; smoking; operation time; lymphovascular invasion; allogeneic blood; HB; AST; ALP; HBsAg; Tumor number; Tumor size; AFP